2021 Interactive Breakout Discussions
Join a virtual breakout discussion group. These are informal, moderated discussions with brainstorming and interactive problem solving, allowing participants from diverse backgrounds to exchange ideas and experiences and develop future collaborations
around a focused topic. This year’s breakouts will take place on Thursday, June 17, 3:00 - 3:35 pm (EDT) AND Friday, June 18, 10:30 - 11:00 am (EDT).
THURSDAY, JUNE 17 | 3:00 - 3:35 PM
TABLE 1: Biodetection In the Real World
Chris Taitt, PhD, Research Biochemist, Center for Biomolecular Science & Engineering, U.S. Naval Research Lab
- Testing in advance of deployment - what is the best strategy?
- Are abbreviated instructions sufficient to inform technicians and how do we account for mis-handling, untrained users?
- How can we decrease costs associated with development, manufacturing, and testing so that tests are affordable by developing nations?
- How can we account for underlying health issues encountered in developing nations?
TABLE 2: Detecting Infectious Disease Threats (IDTs) Where it is Needed
Willy Valdivia-Granda, Founder & CEO, Orion Integrated Biosciences, Inc.
- Periodically previously unknown infectious diseases emerge to affect human, animals and plants; similarly, pathogens present in a population at low levels have re-emerged rapidly in incidence and geographic range with equally grave consequences.
- Given the dynamics of environmental change, travel and the ability of different governments to detect IDTs is key to develop integrative policies to accurately detect infectious diseases.
- The challenges that more 1500 IDTs pose to human, animal or plant health and how different technologies can be applied in diverse operational environments.
- What are the practical requirements, regulatory issues and policy challenges.
TABLE 3: Epic Failures in Research And Development; Share Your Experience To Help Others Feel Better About Themselves
Dave Alburty, CEO, Engineering, InnovaPrep
- What happened?
- What was learned?
- Would you try it again?
- Did it lead to something else that was great?
- Was there collateral damage or benefits?
- How much did it cost?
FRIDAY, JUNE 18 | 10:30 - 11:00 AM
TABLE 1: How to Deal with Using Microbial Genomics to Identify Potential Bioterrorism Attacks
David Ussery, PhD, Director ArC GEM & Professor, Biomedical Informatics, University of Arkansas for Medical Sciences
- How do we address the issue with taxonomy, which has been rapidly changing
- How do we classify potential pathogens “in the wild’, vs. ’terrorist GMOs’ vs. ‘environmental harmless bacteria’ is not as easy as it sounds
TABLE 2: Questions to Consider Before Positioning Your Technology for Adoption
Joany Jackman, PhD, Senior Scientist, Research & Exploratory Development, Johns Hopkins University
- Do you have a clear idea of how your technology and the results provided be used?
- Who will interpret the results of your test?
- How will your test change the current patient treatment or management?
- What does the current patient flow look like and will your test change this?
TABLE 3: Agnostic Biosensing - Removing the Situational and Syndromic Components of Biodetection and Diagnostics
Harshini Mukundan, PhD, Principal Investigator & Team Leader, Chemistry for Biomedical Applications, Los Alamos National Lab
- What are the syndromic and situational information that influence diagnostics and detection
- What is the cost of this bias - in terms of decisions on the choice of sample, method, assay, and time to result
- Strategies to remove the bias from the diagnostics equation
- Role of big data and analytics in this response